Latest & greatest articles for insulin

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on insulin or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on insulin and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for insulin

61. Insulin-like growth factor-1 for the prevention or treatment of retinopathy of prematurity [Cochrane protocol]

Insulin-like growth factor-1 for the prevention or treatment of retinopathy of prematurity [Cochrane protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

62. Insulin versus Oral Therapies for Gestational Diabetes Treatment: Meta-analysis and Network Meta-analysis

Insulin versus Oral Therapies for Gestational Diabetes Treatment: Meta-analysis and Network Meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

63. Glucagon-like peptide (GLP)-1 analogues as an add-on to insulin for adults with type 1 diabetes mellitus [Cochrane protocol]

Glucagon-like peptide (GLP)-1 analogues as an add-on to insulin for adults with type 1 diabetes mellitus [Cochrane protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

64. Education programs for persons with type 1 diabetes using an insulin pump with or without continuous glucose monitoring: a systematic review

Education programs for persons with type 1 diabetes using an insulin pump with or without continuous glucose monitoring: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

65. The associations between maternal BMI or gestational weight gain and insulin sensitivity in offspring: a systematic review and meta-analysis

The associations between maternal BMI or gestational weight gain and insulin sensitivity in offspring: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

66. Systematic review to study the effect of knocking out or inhibiting insulin degrading enzyme (IDE) on steady state and perturbed state glucose

Systematic review to study the effect of knocking out or inhibiting insulin degrading enzyme (IDE) on steady state and perturbed state glucose Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

67. Systematic review and meta-analysis of experiments involving tissue specific insulin receptor knock-outs (IRKOs)

Systematic review and meta-analysis of experiments involving tissue specific insulin receptor knock-outs (IRKOs) Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2019 PROSPERO

68. Meta-analysis of clinical trials examining initial titration of basal insulin on a background of oral glucose-lowering agents in patients with type 2 diabetes

Meta-analysis of clinical trials examining initial titration of basal insulin on a background of oral glucose-lowering agents in patients with type 2 diabetes Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

69. Oral bovine colostrum supplementation and levels of insulin-like growth factor 1 in human adults: systematic review and meta-analysis of randomised controlled trials

Oral bovine colostrum supplementation and levels of insulin-like growth factor 1 in human adults: systematic review and meta-analysis of randomised controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

70. Serum adiponectin, leptin, resistin and insulin resistance levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis

Serum adiponectin, leptin, resistin and insulin resistance levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

71. Glucose-insulin-potassium therapy in cardiac surgery: a meta-analysis and systematic review of randomized trials

Glucose-insulin-potassium therapy in cardiac surgery: a meta-analysis and systematic review of randomized trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2019 PROSPERO

72. Exercise dose for improving insulin sensitivity and in overweight or obese older adults, evaluated in clinical trials

Exercise dose for improving insulin sensitivity and in overweight or obese older adults, evaluated in clinical trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2019 PROSPERO

73. Evaluation of the effect of insulin sensitivity-enhancing lifestyle-and dietary-related adjuncts on anti-depressant treatment response: protocol for a systematic review and meta-analysis

Evaluation of the effect of insulin sensitivity-enhancing lifestyle-and dietary-related adjuncts on anti-depressant treatment response: protocol for a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2019 PROSPERO

74. Evidence for cephalic phase insulin release in humans: a systematic review and meta-analysis

Evidence for cephalic phase insulin release in humans: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

75. Evaluation of efficacy and cost analysis of tenenligliptin in addressing the insulin resistance and glycemic control in Indian patients with type-2 diabetes mellitus

Evaluation of efficacy and cost analysis of tenenligliptin in addressing the insulin resistance and glycemic control in Indian patients with type-2 diabetes mellitus Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

76. Insulin resistance and insulin-like growth factor-I levels in patients with acne: a systematic review and meta-analysis

Insulin resistance and insulin-like growth factor-I levels in patients with acne: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

77. Obesity indicators and insulin resistance: a systematic review

Obesity indicators and insulin resistance: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr

2019 PROSPERO

78. Plant-based dietary indices and adiposity, insulin resistance, pre-diabetes and type 2 diabetes in adults: a systematic review of epidemiological studies

Plant-based dietary indices and adiposity, insulin resistance, pre-diabetes and type 2 diabetes in adults: a systematic review of epidemiological studies Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

79. Auricular therapy for insulin resistance: a systematic review and meta-analysis

Auricular therapy for insulin resistance: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

80. Comparing the efficacy and safety of closed-loop insulin delivery with conventional subcutaneous insulin therapy in patients with type 2 diabetes

Comparing the efficacy and safety of closed-loop insulin delivery with conventional subcutaneous insulin therapy in patients with type 2 diabetes Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO